Since the emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), various vaccines are being developed, with most vaccine candidates focusing...
The coronaviral spike is the dominant viral antigen and the target of neutralizing antibodies. We show that SARS-CoV-2 spike binds biliverdin and bilirubin, the...
Its been a fruit-less bat search. China has tested more than 50,000 animals, including thousands of bats, to find evidence of COVID-19s origins amid a renewed...
The CoronaVac vaccine reduces coronavirus mortality by 97 percent, according to early results of the immunization campaign in Uruguay, which relies heavily on the...
Yahoo is part of Verizon Media. By clicking “Accept all”, you agree that Verizon Media and our partners will store and/or access information on your device...
Scientists from the University of Pittsburgh demonstrated that low doses of an ultrapotent inhalable (or aerosolized) nanobody can prevent and treat acute COVID-19...
Hit by a multibillion-euro lawsuit and rare side-effects, the jab that was going to save the world has an uncertain outlook
Austria, Denmark and Norway have dropped viral vector vaccines from their vaccination campaigns.
Delivery of adenovirus vector vaccines can trigger mutant proteins: study
EMA logs more clotting cases after AstraZeneca shot, death rate lower